1. Home
  2. CODX vs ABVE Comparison

CODX vs ABVE Comparison

Compare CODX & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • ABVE
  • Stock Information
  • Founded
  • CODX 2013
  • ABVE 2019
  • Country
  • CODX United States
  • ABVE Canada
  • Employees
  • CODX N/A
  • ABVE N/A
  • Industry
  • CODX Medical/Dental Instruments
  • ABVE Packaged Foods
  • Sector
  • CODX Health Care
  • ABVE Consumer Staples
  • Exchange
  • CODX Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • CODX 22.0M
  • ABVE 18.6M
  • IPO Year
  • CODX 2017
  • ABVE N/A
  • Fundamental
  • Price
  • CODX $0.35
  • ABVE $0.68
  • Analyst Decision
  • CODX Hold
  • ABVE
  • Analyst Count
  • CODX 1
  • ABVE 0
  • Target Price
  • CODX $1.00
  • ABVE N/A
  • AVG Volume (30 Days)
  • CODX 163.5K
  • ABVE 165.1K
  • Earning Date
  • CODX 05-08-2025
  • ABVE 02-15-2025
  • Dividend Yield
  • CODX N/A
  • ABVE N/A
  • EPS Growth
  • CODX N/A
  • ABVE N/A
  • EPS
  • CODX N/A
  • ABVE N/A
  • Revenue
  • CODX $3,915,160.00
  • ABVE $275,376,450.00
  • Revenue This Year
  • CODX N/A
  • ABVE N/A
  • Revenue Next Year
  • CODX N/A
  • ABVE N/A
  • P/E Ratio
  • CODX N/A
  • ABVE N/A
  • Revenue Growth
  • CODX N/A
  • ABVE N/A
  • 52 Week Low
  • CODX $0.28
  • ABVE $0.25
  • 52 Week High
  • CODX $2.23
  • ABVE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • CODX 42.44
  • ABVE N/A
  • Support Level
  • CODX $0.32
  • ABVE N/A
  • Resistance Level
  • CODX $0.38
  • ABVE N/A
  • Average True Range (ATR)
  • CODX 0.05
  • ABVE 0.00
  • MACD
  • CODX 0.01
  • ABVE 0.00
  • Stochastic Oscillator
  • CODX 60.87
  • ABVE 0.00

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: